AMP Capital Investors’s Ionis Pharmaceuticals IONS Stock Holding History

AMP Capital Investors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-31,333	Closed	-$1.41M	–	1201
2021 Q1	$1.41M	Hold	31,333	–	–	0.01%	801
2020 Q4	$1.79M	Hold	31,333	–	–	0.01%	773
2020 Q3	$1.52M	Buy	31,333 +402	+1%	+$22.3K	0.01%	755
2020 Q2	$1.84M	Sell	30,931 -17	-0.1%	-$946	0.01%	717
2020 Q1	$1.49M	Sell	30,948 -11,194	-27%	-$624K	0.01%	700
2019 Q4	$2.54M	Sell	42,142 -28,832	-41%	-$1.72M	0.01%	718
2019 Q3	$4.19M	Buy	70,974 +44,513	+168%	+$2.9M	0.02%	588
2019 Q2	$1.71M	Buy	+26,461	New	+$1.87M	0.01%	788
2016 Q4	–	Sell	-39,068	Closed	-$1.39M	–	1254
2016 Q3	$1.39M	Sell	39,068 -116,571	-75%	-$3.65M	0.01%	800
2016 Q2	$3.6M	Buy	155,639 +118,360	+317%	+$3.82M	0.02%	571
2016 Q1	$1.44M	Sell	37,279 -100	-0.3%	-$4.06K	0.01%	766
2015 Q4	$2.29M	Sell	37,379 -21,753	-37%	-$1.17M	0.02%	687
2015 Q3	$2.25M	Sell	59,132 -33,731	-36%	-$1.75M	0.02%	658
2015 Q2	$5.21M	Buy	92,863 +71,700	+339%	+$4.56M	0.03%	476
2015 Q1	$1.37M	Buy	+21,163	New	+$1.44M	0.01%	819
2013 Q4	–	Sell	-5,445	Closed	-$209K	–	1247
2013 Q3	$209K	Buy	+5,445	New	+$163K	﹤0.01%	1134

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

AMP Capital Investors's IONS Position: Q2 2021 in Review

AMP Capital Investors sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 31,333 shares — an estimated $1.41M sold.

AMP Capital Investors first reported a position in IONS in Q3 2013 and held it in 16 quarters. The position peaked at $5.21M in Q2 2015. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

AMP Capital Investors reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
AMP Capital Investors sold 31,333 Ionis Pharmaceuticals shares in Q2 2021, an estimated $1.41M.
AMP Capital Investors first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 16 quarters.
AMP Capital Investors's Ionis Pharmaceuticals position peaked at $5.21M in Q2 2015.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on AMP Capital Investors's 13F filing for Q2 2021, filed 16 Aug 2021.